RG
ALXN

Rathbones Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,090
Closed -$200K 441
2021
Q2
$200K Buy
+1,090
New +$200K ﹤0.01% 402
2021
Q1
Sell
-2,790
Closed -$436K 427
2020
Q4
$436K Hold
2,790
0.01% 293
2020
Q3
$319K Hold
2,790
0.01% 302
2020
Q2
$313K Buy
2,790
+130
+5% +$14.6K 0.01% 289
2020
Q1
$239K Hold
2,660
0.01% 270
2019
Q4
$288K Hold
2,660
0.01% 278
2019
Q3
$261K Hold
2,660
0.01% 285
2019
Q2
$348K Hold
2,660
0.01% 258
2019
Q1
$360K Hold
2,660
0.01% 246
2018
Q4
$259K Hold
2,660
0.01% 270
2018
Q3
$370K Buy
2,660
+100
+4% +$13.9K 0.01% 237
2018
Q2
$318K Buy
2,560
+520
+25% +$64.6K 0.01% 239
2018
Q1
$227K Hold
2,040
0.01% 278
2017
Q4
$244K Hold
2,040
0.01% 276
2017
Q3
$286K Hold
2,040
0.01% 252
2017
Q2
$248K Buy
2,040
+50
+3% +$6.08K 0.01% 265
2017
Q1
$241K Buy
1,990
+100
+5% +$12.1K 0.01% 273
2016
Q4
$231K Hold
1,890
0.01% 267
2016
Q3
$232K Hold
1,890
0.01% 274
2016
Q2
$221K Buy
1,890
+50
+3% +$5.85K 0.01% 265
2016
Q1
$256K Hold
1,840
0.02% 239
2015
Q4
$308K Hold
1,840
0.02% 229
2015
Q3
$288K Hold
1,840
0.02% 240
2015
Q2
$333K Buy
1,840
+200
+12% +$36.2K 0.02% 239
2015
Q1
$284K Hold
1,640
0.02% 254
2014
Q4
$303K Hold
1,640
0.02% 249
2014
Q3
$272K Hold
1,640
0.02% 252
2014
Q2
$256K Hold
1,640
0.02% 250
2014
Q1
$249K Buy
+1,640
New +$249K 0.02% 240
2013
Q4
Sell
-1,965
Closed -$228K 269
2013
Q3
$228K Buy
+1,965
New +$228K 0.03% 231